We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+3.43%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.79B
AUM Growth
+$618M
Cap. Flow
+$595M
Cap. Flow %
33.32%
Top 10 Hldgs %
16.68%
Holding
4,499
New
1,229
Increased
1,153
Reduced
1,264
Closed
790

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$51.7M
2
MSFT icon
Microsoft
MSFT
+$40.6M
3
AMZN icon
Amazon
AMZN
+$29.2M
4
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$20.2M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$19.9M

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$31.8M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$27.9M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$21.9M
4
XLV icon
State Street Health Care Select Sector SPDR ETF
XLV
+$18.4M
5
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$16.3M

Sector Composition

Rank Sector Weight
1 Technology 13.59%
2 Financials 10.04%
3 Healthcare 8.35%
4 Industrials 7.34%
5 Consumer Discretionary 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DCP
4201
DELISTED
DCP Midstream, LP
DCP
– –
-10,229
Closed -$359K
RUTH
4202
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
– –
-3,978
Closed -$97K
ACOR
4203
DELISTED
Acorda Therapeutics
ACOR
– –
-7
Closed -$21K
MGI
4204
DELISTED
MoneyGram International, Inc. New
MGI
– –
-12,472
Closed -$107K
SEAC
4205
DELISTED
Seachange International Inc
SEAC
– –
-615
Closed -$33K
CYAD
4206
DELISTED
Celyad Oncology SA American Depositary Shares
CYAD
– –
-32
Closed -$1K
JNCE
4207
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
– –
-1,378
Closed -$31K
BSMX
4208
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
– –
-1,800
Closed -$13K
DTEA
4209
DELISTED
DAVIDsTEA Inc. Common Stock
DTEA
– –
-632
Closed -$2K
PLXP
4210
DELISTED
PLx Pharma Inc. Common Stock
PLXP
– –
-660
Closed -$2K
NVCN
4211
DELISTED
Neovasc Inc.
NVCN
– –
0
– –
AGRX
4212
DELISTED
Agile Therapeutics
AGRX
– –
-2
Closed -$8K
FSTX
4213
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
– –
-61
Closed -$4K
OIIM
4214
DELISTED
02Micro International
OIIM
– –
-861
Closed -$1K
CYRN
4215
DELISTED
CYREN Ltd.
CYRN
– –
-17
Closed -$1K
RFP
4216
DELISTED
Resolute Forest Products Inc.
RFP
– –
-42
Closed –
ELVT
4217
DELISTED
Elevate Credit, Inc.
ELVT
– –
-3,095
Closed -$21K
SRNE
4218
DELISTED
Sorrento Therapeutics, Inc.
SRNE
– –
-100
Closed -$1K
ATNX
4219
DELISTED
Athenex, Inc. Common Stock
ATNX
– –
-783
Closed -$266K
SJI
4220
DELISTED
South Jersey Industries, Inc.
SJI
– –
-8,122
Closed -$229K
VIVE
4221
DELISTED
VIVEVE MED INC
VIVE
– –
-1
Closed -$3K
DS
4222
DELISTED
Drive Shack Inc.
DS
– –
-15,150
Closed -$72K
PCSB
4223
DELISTED
PCSB Financial Corporation
PCSB
– –
-887
Closed -$19K
CLVS
4224
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-48
Closed -$3K
AERI
4225
DELISTED
Aerie Pharmaceuticals
AERI
– –
-503
Closed -$27K
167 168
169
170 171

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
GAMH
Greenwoods Asset Management (HK) Hong Kong $3.88B AUM 23.82% 1-Year Est. Return
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2018 Portfolio in Review

As of Q2 2018, Tower Research Capital (TRC) held 4,499 positions worth $1.79B, up 53% from $1.17B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Tower Research Capital (TRC) deployed $595M of net new capital in Q2 2018, opening 1,229 new positions and adding to 1,153 existing holdings. Its largest new stake was JPMorgan Chase: 180,678 shares worth $18.8M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 4.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $31.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2018 buy was JPMorgan Chase: 180,678 shares worth $18.8M.
  • Tower Research Capital (TRC) added most to Apple in Q2 2018, an estimated $51.7M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2018 reduction was iShares MSCI EAFE ETF, cutting an estimated $31.8M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Dow Jones REIT ETF in Q2 2018, selling an estimated $6.85M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 17% of its $1.79B portfolio in Q2 2018.
  • Tower Research Capital (TRC) opened 1,229 new positions and closed 790 in Q2 2018.
  • Tower Research Capital (TRC)'s portfolio value rose 53% quarter-over-quarter to $1.79B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2018, filed 15 Aug 2018.